Clinical trial
A Phase II Single Arm Trial of Stereotactic Body Proton Radiotherapy (SBPT) for Hepatocellular Carcinoma
NCT04805788 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Single Arm Trial of Stereotactic Body Proton Radiotherapy (SBPT) for Hepatocellular Carcinoma
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 24, 2021
- Completion date
- January 28, 2025
- Enrollment
- 9 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent hepatocellular carcinoma, stage i hepatocellular carcinoma ajcc v8, stage ii hepatocellular carcinoma ajcc v8, stage iii hepatocellular carcinoma ajcc v8